Award

Dagar dissects a prostate cancer driver

Meet a JBC/Tabor award winner
Alyson Smith
February 08, 2020

Many cancer treatments block hormones that drive tumor cell division and metastasis. These therapies only shrink tumors temporarily, however, as cancer cells can use alternative signaling pathways to reduce their hormone dependence. Drugs that target these pathways may halt tumor growth and extend patient survival.

Dagar-Manisha-300x300.jpg
Manisha Dagar

Manisha Dagar has uncovered the details of a signaling pathway that drives advanced prostate cancer.

Dagar has always been interested in science, especially biology. Her mother encouraged her to pursue higher education and a research career. She earned an undergraduate degree in biotechnology, and a summer internship at the National Centre for Disease Control in New Delhi gave her the lab experience she needed to pursue a Ph.D. at Amity Institute of Biotechnology, Amity University in Haryana, India.

At Amity University, Dagar decided to study the molecular biology of cancer. She joined Gargi Bagchi’s lab, where she studies androgens, the male sex hormones, in prostate cancer. Previous research revealed that protein kinase A, which phosphorylates proteins to change their functions, can activate androgen signaling in the absence of hormones. Dagar and colleagues in the lab discovered how this aberrant activity contributes to prostate cancer progression.

Dagar studied protein kinase A function in a cell line derived from a prostate cancer patient. After optimizing protocols to measure protein levels in these cells, Dagar could track how blocking protein kinase A phosphorylation activity changed androgen signaling. Her work has revealed new drug targets that could treat advanced prostate cancer.

Dagar successfully defended her Ph.D. thesis in January. She hopes to pursue postdoctoral research studying cell signaling. Outside the lab, she enjoys reading and traveling.

Targeting molecular chaperones to stop prostate cancer

Testosterone and related androgen hormones act through the androgen receptor, which is stabilized in the cytoplasm by the molecular chaperone HSP90. When the receptor binds an androgen, it releases HSP90 and enters the nucleus to regulate gene expression. Androgens thus direct the development and maintenance of the prostate gland but also drive prostate cancer.

Manisha Dagar and her colleagues knocked down protein kinase A to learn how this enzyme affects androgen receptor nuclear entry. They discovered that protein kinase A phosphorylates HSP90, causing it to release the androgen receptor. The receptor then binds HSP27, a different molecular chaperone, which helps it enter the nucleus. Once in the nucleus, the receptor can bind certain DNA regions to turn on genes.

Blocking protein kinase A activity blocked testosterone-induced HSP90 phosphorylation, androgen receptor-HSP90 dissociation, androgen receptor-HSP27 binding, androgen receptor nuclear entry, changes in gene expression and increase in proliferation of prostate cancer cells.

“By targeting HSP90 phosphorylation by protein kinase A, androgen signaling in prostate cancer cells can be blocked,” Dagar said. “This can be used as a therapeutic target for treatment of prostate cancer.”

As first author on the paper reporting this research, Dagar received a 2020 Journal of Biological Chemistry/Herbert Tabor Early Career Investigator Award.

Dagar and her colleagues continue to search for ways to block prostate cancer cell proliferation, including in patients that express hormone-independent variants of the androgen receptor.

Alyson Smith

Alyson Smith is a recent Ph.D. graduate from Scripps Research in La Jolla, California. Follow her on Twitter.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Meet Sarina Neote
Blotter

Meet Sarina Neote

February 19, 2020

As the ASBMB’s science policy manager, she advocates for policies that strengthen the scientific workforce and promote an inclusive environment that is supportive of discovery.

Glycobiology awards; honors for Hall; remembering Saffran, Kornberg, Herrmann
Member News

Glycobiology awards; honors for Hall; remembering Saffran, Kornberg, Herrmann

February 17, 2020

Awards, promotions and more. Find out what's going on in the lives of ASBMB members.

New ASBMB members
Member News

New ASBMB members

February 10, 2020

The American Society for Biochemistry and Molecular Biology welcomed more than 1,300 new member in November.

Belfort receives honorary degree; Evensen wins Marshall; remembering Mildvan, Fridovich
Member News

Belfort receives honorary degree; Evensen wins Marshall; remembering Mildvan, Fridovich

February 10, 2020

Awards, honors, promotions and more. Find out what's going on in the lives of ASBMB members.

Selenium led Zhao from icy hometown to German hospitality
Award

Selenium led Zhao from icy hometown to German hospitality

February 09, 2020

JBC/Tabor award winner Wenchao Zhao studies Keshan disease, a nutrient deficiency named for the county in northeastern China where he grew up.

Varghese roams from forests to enzymes
Award

Varghese roams from forests to enzymes

February 07, 2020

JBC/Tabor award winner Febin Varghese studies how iron-only nitrogenase responds to oxygen, with the long-term goal of increasing crop production.